Skip to content

Clinical Study on Continuous Suture of Endoscopic Mucosal Defects

Clinical Study on Continuous Suture of Mucosal Defects After Endoscopic Mucosal Lesion Resection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05190042
Enrollment
62
Registered
2022-01-13
Start date
2022-01-18
Completion date
2022-07-30
Last updated
2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Polyp, Gastrointestinal Neoplasms

Keywords

Endoscopic mucosal resection, Endoscopic submucosal dissection, Gastrolintestinal polyps, Continuous suture, Clips

Brief summary

The use of clips to completely clip mucosal defects after ESD/EMR can reduce postoperative adverse events, but the rate of incomplete mucosal defects closure is high. The continuous suture technique can completely close the mucosal defects by using surgical sutures and clips to suture the mucosal defects after ESD/EMR. In this study, a clinical randomized controlled study was conducted in our hospital. A total of 62 enrolled patients were divided into two groups, 31 patients were set as a treatment group using continuous suture technique to close post-EMR/ESD mucosal/submucosal defects, the rest patients were set as a control group using clips. The safety and effectiveness of continuous sutures and clips to clamp the post-EMR/ESD mucosal/submucosal defect were compared in the two groups. The complete mucosal/submucosa defects closure rates were the primary outcome.

Detailed description

Endoscopic submucosal resection (EMR) or submucosal dissection (ESD) for gastrointestinal lesions were used to treat early gastrointestinal cancer or large benign polyps, and their complete resection rates were high, which greatly reduce unnecessary surgical operations. However, after endoscopic resection of mucosal/submucosal lesions, large mucosal/submucosal defects may be created. These defects may cause more delayed postoperative adverse events (bleeding, perforation). The use of clips to completely seal the mucosal defect after gastrointestinal mucosal/submucosal lesion resection can significantly reduce postoperative adverse events, but the rate of incomplete mucosal defects closure is high. The surgical sutures combined with clips to close the mucosal defect after surgery significantly increased the complete closure rates of the post-EMR/ESD mucosal/submucosal defect. This study intends to further determine its safety and effectiveness through a clinical randomized controlled study, and standardize indications and contraindications. A total of 62 enrolled patients were allocated into two groups, 31 patients were set as a treatment group using continuous suture technique to close post-EMR/ESD mucosal/submucosal defects, the rest patients were set as a control group using clips. The safety and effectiveness of continuous sutures and clips to clamp the post-EMR/ESD mucosal/submucosal defect were compared in the two groups. The primary outcome was complete mucosal/submucosa defects closure rates. The secondary outcomes were the closure time, closure speed, and immediate bleeding during the operation as well as delayed bleeding, delayed perforation, and polyps syndrome after resection.

Interventions

DEVICECotinuous suture

Cotinuous suture using surgery thread

DEVICEClips

Hemostatic clips

Sponsors

Affiliated Hospital to Academy of Military Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

This was a single-blind study where patients were not informed about their randomization allocation.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. The indications for endoscopic resection were large (≥20mm in diameter), nonpedunculated, benign, and early malignant mucosal or submucosal gastric or colorectal lesions. 2. Written informed consent

Exclusion criteria

1. The tumor has spread to the muscularis layer, lymph nodes, or distal metastases; 2. Multiple lesions (≥20mm in diameter) ; 3. Underlying bleeding disorder; 4. The platelet count less than 50×10\^9/L; 5. Serious cardio-pulmonary, hepatic or renal disease; 6. Intolerance to endoscopy; 7. Other high-risk conditions or disease (such as massive ascites, etc.); 8. Pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
The rates of complete closure of mucosal/submucosal defects1dayWhen the clips were applied next to each other and there were no substantial submucosal areas in the closure line

Secondary

MeasureTime frameDescription
The closure speed1dayThe closure speed was defined as the resection area divided by 10x the duration of the ligation procedure (cm2 /10 minutes).
Immediate bleeding1 dayImmediate bleeding refers to those episodes of hemorrhage that occurred during the procedure and lasted more than 30 seconds or required endoscopic treatment.
The duration time of closure1 dayThe duration of closure was defined as the interval from insertion of the first clip until complete or incomplete closure
Delayed perforation14 daysDelayed perforation was defined as the presence of free air on abdominal CT or radiography after completion of the procedure in patients without perforation during EMR/ESD and no symptoms of peritoneal irritation after EMR/ESD
Post polypectomy syndrome14 daysPost polypectomy syndrome was defined by symptoms of pain, fever, leukocytosis, peritoneal tenderness, and guarding.
Delayed bleeding14 daysDelayed bleeding was defined as bleeding requiring emergency endoscopic hemostasis or transfusion or the presence of hemoglobin loss≥2 g/dL after EMR/ESD

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026